IMMUNOHISTOCHEMICAL DEMONSTRATION OF RAS P21 ONCOGENE PRODUCT IN NORMAL, BENIGN, AND MALIGNANT HUMAN THYROID TISSUES

被引：0
|
作者：
MIZUKAMI, Y
NONOMURA, A
HASHIMOTO, T
TERAHATA, S
MATSUBARA, F
MICHIGISHI, T
NOGUCHI, M
机构：
[1] KANAZAWA UNIV,SCH MED,CENT CLIN LAB,KANAZAWA,ISHIKAWA 920,JAPAN
[2] KANAZAWA UNIV,SCH MED,DEPT NUCL MED,KANAZAWA,ISHIKAWA 920,JAPAN
[3] KANAZAWA UNIV,SCH MED,DEPT SURG,KANAZAWA,ISHIKAWA 920,JAPAN
[4] KANAZAWA UNIV,SCH MED,DEPT PATHOL,KANAZAWA,ISHIKAWA 920,JAPAN
来源：
CANCER | 1988年 / 61卷 / 05期
关键词：
D O I：
10.1002/1097-0142(19880301)61:5<873::AID-CNCR2820610504>3.0.CO;2-W
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：873 / 880
页数：8
相关论文
共 50 条
  • [31] DIFFERENTIAL (HA-, K- AND N-) RAS P21 EXPRESSION IN BENIGN AND MALIGNANT HUMAN THYROID-TUMORS - AN IMMUNOHISTOCHEMICAL STUDY
    MIZUKAMI, Y
    NONOMURA, A
    MICHIGISHI, T
    NOGUCHI, M
    NAKAMURA, S
    HASHIMOTO, T
    ANTICANCER RESEARCH, 1995, 15 (03) : 755 - 759
  • [32] INTERACTION OF RAS ONCOGENE PRODUCT P21 WITH GUANINE-NUCLEOTIDES
    HOSHINO, M
    CLANTON, DJ
    SHIH, TY
    KAWAKITA, M
    HATTORI, S
    JOURNAL OF BIOCHEMISTRY, 1987, 102 (03): : 503 - 511
  • [33] IMMUNOHISTOCHEMICAL ANALYSIS OF RAS P21 EXPRESSION IN NORMAL, PREMALIGNANT AND MALIGNANT ORAL-MUCOSA
    KANNAN, S
    BALARAM, P
    PILLAI, MR
    CHANDRAN, GJ
    NAIR, MK
    INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (04) : 700 - 702
  • [34] IMMUNOHISTOCHEMICAL ANALYSIS OF THE RAS ONCOGENE PROTEIN PRODUCT IN HUMAN THYROID NEOPLASMS
    PAPADIMITRIOU, K
    YIAGNISIS, M
    TOLIS, G
    SPANDIDOS, DA
    ANTICANCER RESEARCH, 1988, 8 (05) : 1149 - 1149
  • [35] IMMUNOHISTOCHEMICAL ANALYSIS OF THE RAS ONCOGENE PROTEIN PRODUCT IN HUMAN THYROID NEOPLASMS
    PAPADIMITRIOU, K
    YIAGNISIS, M
    TOLIS, G
    SPANDIDOS, DA
    ANTICANCER RESEARCH, 1988, 8 (06) : 1223 - 1227
  • [36] IMMUNOHISTOCHEMICAL STAINING OF COLORECTAL TISSUES WITH MONOCLONAL-ANTIBODIES TO RAS ONCOGENE P21 PRODUCT AND CARBOHYDRATE DETERMINANT ANTIGEN 19-9
    ALLEN, DC
    FOSTER, H
    ORCHIN, JC
    BIGGART, JD
    JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (02) : 157 - 162
  • [37] EVIDENCE OF ENHANCEMENT OF THE RAS ONCOGENE PROTEIN PRODUCT (P21) IN A SPECTRUM OF HUMAN-TUMORS
    DEBIASI, F
    DELSAL, G
    HAND, PH
    INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (03) : 431 - 435
  • [38] THE H-RAS ONCOGENE PRODUCT P21 AND PROGNOSIS IN HUMAN BREAST-CANCER
    WATSON, DMA
    ELTON, RA
    JACK, WJL
    DIXON, JM
    CHETTY, U
    MILLER, WR
    BREAST CANCER RESEARCH AND TREATMENT, 1991, 17 (03) : 161 - 169
  • [39] RAS ONCOGENE MUTATIONS IN BENIGN AND MALIGNANT THYROID NEOPLASMS
    KARGA, H
    LEE, JK
    VICKERY, AL
    THOR, A
    GAZ, RD
    JAMESON, JL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04): : 832 - 836
  • [40] DETECTION OF THE INTRACELLULAR RAS P21 ONCOGENE PRODUCT BY FLOW-CYTOMETRY
    YOUNG, HA
    KLEIN, RA
    SHIH, TY
    MORGAN, AC
    SCHROFF, RW
    ANALYTICAL BIOCHEMISTRY, 1986, 156 (01) : 67 - 71
12345